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Background: Reduced arterial elasticity is an important mediator of accelerated atherogenesis
and consequent increased cardiovascular morbidity in obstructive sleep apnea (OSA). The aim
of our study was to investigate whether continuous positive airway pressure (CPAP) therapy
may improve arterial elasticity in subjects with OSA.
Methods: In 44 subjects with OSA, we measured arterial elasticity by applanation tonometry
before and after 6 months of treatment with CPAP. Nine OSAþ subjects withdrew from the
study.
Results: The 35 patients with OSA who completed the 6-month CPAP treatment showed
a marked reduction in both the large artery (LAEI, PZ 0.001) and small artery (SAEI,
PZ 0.009) elasticity indices, independent of potential confounders. In OSAþ subjects who
withdrew from the study, SAEI and LAEI did not change significantly over time.
Conclusions: Six months of CPAP therapy improves arterial elasticity in subjects with OSA.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Multiple studies have demonstrated that obstructive sleep
apnea (OSA) is strongly associated with known vascular risknt of Cardiology, Uludag
59 Go¨ru¨kle, Bursa, Turkey.
mail.com (T. Senturk).
0 Elsevier Ltd. All rights reservedfactors and increased cardiovascular morbidity.1,2 Of note,
OSA itself may act as an independent risk factor for hyper-
tension, ischemic heart disease, stroke, and arrhythmia.3e5
Although the exact mechanisms by which OSA may be
linked to increased vascular risk are not entirely under-
stood,6e8 it has been recently suggested that endothelial
dysfunction and arterial elasticity may represent a pivotal
link.9 Arterial compliance is defined as the ability of an artery
to expand and recoil with cardiac pulsation and relaxa-
tion.10,11 Measurements of arterial elasticity, using.
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regarding vascular health and a decrease in arterial compli-
ance can be regarded as a valid marker of early vascular
dysfunction. Of great interest, estimation of arterial elas-
ticity may serve not only as cardiovascular risk assessment
but also as a surrogate marker of treatment benefits.13,14
Nasal continuous positive airway pressure (CPAP) has
become the gold standard of treatment of sleep-disordered
breathing.15 When worn during sleep, CPAP effectively
reduces or eliminates most sleep-disordered breathing
events, resulting in a global improvement in sleep archi-
tecture.16 Evidence also suggests that CPAP may results in
positive cardiovascular and metabolic effects in patients
with OSA, ultimately leading to an improvement in the
cardiovascular risk profile.17,18 Previous studies have shown
that CPAP therapy can improve microvascular endothelial
function and decrease stiffness of the central to middle-
sized arteries.19,20 However, data on the long-term impact
of CPAP on measures of arterial elasticity in patients with
OSA are lacking. The aim of our study was to fill this gap and
to evaluate the changes induced by CPAP on large and small
arterial elasticity indices (LAEI and SAEI, respectively). The
analysis of LAEI and SAEI allows an evaluation of the elas-
ticity of the large conduit arteries and the small microcir-
culatory arteries. Although LAEI and SAEI measure different
aspects of arterial elasticity, a reduction of both indices has
been linked to an increased vascular risk.13
Methods
Study participants and diagnostic polysomnography
We initially considered for our study 97 consecutive
subjects referred to our laboratory because of symptoms of
OSA for diagnostic polysomnography. Exclusion criteria
were as follows: use of immunomodulatory drugs; history of
coronary artery disease, peripheral artery disease, or
cerebrovascular disease according to medical history and
clinical examination; transplantation; alcohol and drug
abuse; HIV infection; significant medical illnesses (active
infections, autoimmune disorders, malignancy, liver
disease, chronic obstructive pulmonary disease, asthma,
neuromuscular disorders).
In all participants, overnight polysomnography was per-
formed with a Compumedics Sleepwatch System (Compu-
medics p-series: Compumedics, Melbourne, Australia). The
study subjects reported to the sleep laboratory at approx-
imately 8:30 p.m., and polysomnography was started at
approximately 10:30 p.m. Polysomnographic recordings
included two electroencephalography channels (C3/A2 and
O2/A1), two electrooculogram channels, one submental
electromyogram channel, and one electrocardiography
channel. Ventilatory monitoring included recording of oro-
nasal airflow (with an oronasal thermistor), hemoglobin
oxygen saturation by pulse oximetry (SaO2 was measured
via a finger oximeter), respiratory movement of the chest
(with inductive plethysmography), and abdomen and body
posture. Sleep staging was performed according to the
standard criteria of Rechtschaffen and Kales.21 Nasal
airflow was carefully analyzed in order to assess ventilation
during sleep. Apnea was defined as an episode of airflowcessation lasting at least 10 s. Hypopnea was defined as an
episode of reduced thermistor signal amplitude of at least
50% and an associated drop in oxygen saturation of at least
3% or an arousal lasting 10 s or longer. The sum of the time
elapsed in periods of apnea and hypopnea was divided by
the total sleep time to obtain the Apnea-Hypopnea Index
(AHI). OSA was diagnosed when the patient’s AHI was more
than or equal to 5. The Epworth Sleepiness Scale (ESS) was
used to measure excessive sleepiness.22
The study protocol was approved by the Ethics Committee
of the Uludag University Medical School. A written informed
consent was obtained from all participants.
Definition of cardiovascular risk factors
Age was analyzed as a continuous variable. Body mass index
(BMI) was calculated by taking the weight (in kilograms) over
the height (in meters-squared). The use of cardiac drugs
(b-blockers, statins, calcium antagonists, angiotensin-con-
verting enzyme inhibitors, aspirin) was recorded in all
participants. In our study, smoking was defined as regular
smoking of cigarettes. Diabetesmellituswas diagnosed on the
basis of fasting blood glucose concentrations 126 mg/dL or
current useofantidiabeticmedications.Arterial hypertension
was defined as active treatment with antihypertensive
medications or documentation of systolic blood pressure
140 mmHgand/ordiastolicbloodpressure 90 mmHgonat
least two separate occasions. Serum samples were measured
for lipid variables using commercially available kits on a Hita-
chi 7350 Autoanalyzer (Hitachi Ltd., Tokyo, Japan).
Measurements of arterial elasticity
All measurements of arterial elasticity were performed on
the radial artery using the noninvasive technique of arterial
applanation tonometry. The PulseWave Sensor HDI (Hyper-
tension Diagnostics, Eagan, MN, USA) was used to deter-
mine LAEI and SAEI. Applanation tonometry is based on the
principle that when the curved surface of a rounded pres-
sure-containing chamber (in this case, an artery) is partially
flattened, pressures are normalized and a sensor placed on
the flattened surface can record the pressure in the
chamber.12,23 This technique, which analyzes the signal-
averaged radial artery waveform based on a modified
Windkessel model, correlates well with other methods that
measure hemodynamic parameters in humans.13
Data analysis
Continuous variables are presented as means  standard
deviation. Categorical variables are reported as counts and
compared using the c2-test. Differences between subjects
with and without OSA were evaluated by the unpaired
t-test. Within-group comparisons were performed using the
paired Student’s t-test. Correlations among the study
variables were examined by Pearson’s correlation. Simple
linear regression analysis was used to assess whether
changes in SAEI and LAEI were independent of potential
confounders, including age, gender, BMI, blood pressure
values, heart rate, lipid parameters and the use of cardiac
drugs. All statistical analyses were performed using the
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two-tailed P value < 0.05 was regarded as significant.
Results
General characteristics of the study participants
OSA was diagnosed in a total of 66 subjects. Twenty-two
individuals with OSA did not receive CPAP treatment and
were excluded from the analysis. A total of 44 subjects with
OSA (OSAþ) and 31 subjects without OSA (OSA) were
finally included. The baseline characteristics of subjects
with and without OSA are depicted in Table 1. There were
no significant differences between the two groups in terms
of age, BMI, blood pressure parameters, diabetes, and lipid
profile. In addition, the use of cardiovascular drugs (statins,
angiotensin-converting enzyme inhibitors, or angiotensin II
receptor blockers) did not differ in the two groups (data not
shown). Compared with the OSA group, OSAþ subjects
showed higher ESS scores, systolic blood pressure, diastolic
blood pressure, and mean arterial pressure. LAEI and SAEI
values at baseline showed a trend toward lower values in
OSAþ subjects compared with OSA individuals; this
difference, however, failed to reach statistical significance
probably due to the small sample size.
Polysomnographic measures
The polysomnographic measures of nocturnal sleep in the
two study groups are shown in Table 2. As expected, the
two groups differed for a number of polysomnographic
parameters, the only exceptions being the time of REM
sleep and the average oxygen saturation while awake.
Baseline determinants of arterial elasticity in the
OSAD group
Pearson’s correlation coefficients were determined to
assess whether baseline measures of arterial elasticityTable 1 General characteristics of subjects with and without O
OSAþ (nZ 66)
Age, years 52 10
Sex, males/females 54/12
Smoking, yes/no 12/54
Hypertension, yes/no 25/41
Diabetes mellitus, yes/no 10/56
Epworth scale 13 4
BMI, kg/m2 32 5
SBP, mmHg 142 16.7
DBP, mmHg 84 10
MBP, mmHg 106 16
Total cholesterol, mmol/L 5.2 0.9
HDL cholesterol, mmol/L 1.1 0.3
Triglycerides, mmol/L 1.8 0.7
LAEI, mL/mmHg 10 13 4
SAEI, mL/mmHg 100 5 3
BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic bl
protein; LAEI: large artery elasticity index, SAEI: small artery elasticiwere associated with the general or the polysomnographic
characteristics of the OSAþ group. Both SAEI and LAEI were
negatively correlated with systolic blood pressure
(rZ0.463, PZ 0.05 and rZ0.483, PZ 0.03, respec-
tively). In addition, SAEI showed an inverse correlation with
diastolic blood pressure (rZ0.422, PZ 0.01). No other
significant correlation was found.
Effect of CPAP therapy on arterial elasticity in the
OSAD group
In the 44 subjects in the OSAþ group, we measured arterial
elasticity before and after 6 months of treatment with
CPAP. Nine OSAþ subjects withdrew from the study. Table 3
shows the changes in LAEI and SAEI in completers and
noncompleters. After 6 months of CPAP treatment, the
completer group (nZ 35) showed a marked reduction in
both the LAEI (PZ 0.001, Fig. 1) and SAEI (PZ 0.009,
Fig. 2) indices. In OSAþ subjects who withdrew from the
study (nZ 9), SAEI and LAEI did not change over time.
Multivariable analysis
We used simple linear regression analysis to determine
whether the magnitude of changes in SAEI and LAEI (ΔSAEI
and ΔLAEI) in the completers were independent of
potential confounders. Results showed that both ΔSAEI
(bZ0.41, tZ2.9, PZ 0.009) and ΔLAEI (bZ0.38,
tZ2.7, PZ 0.01) were not influenced by the con-
founding effect of other clinical and demographic
variables.
Discussion
This study examined the effect of CPAP therapy on arterial
elasticity in OSAþ subjects. We found that six months of 6
months of CPAP therapy significantly improved arterial
elasticity of large and small arteries in patients with OSA,
independent of potential confounders.SA.
OSA (nZ 31) P
50 9 ns
20/11 ns
5/26 ns
10/21 ns
2/29 ns
10.3 4 0.04
31 5 ns
132 16 0.04
77 9 0.05
97 11 0.05
4.9 0.6 ns
1.1 0.2 ns
1.7 0.7 ns
14 5 ns
6 3 ns
ood pressure, MBP: mean blood pressure, HDL: high-density lipo-
ty index, ns: not significant.
Table 2 Polysomnographic data of subjects with and without OSA.
OSAþ (nZ 66) OSA (nZ 31) P
Time of REM sleep, min 58 30 58  36 NS
Time of sleep stage 3e4, min 28 25 58 34 <0.001
Sleep efficiency, % 84 9 76 14 0.01
Average O2 saturation while awake, % 94 3 94 4 NS
Average O2 saturation during sleep, % 89 6 95 2 <0.001
Average desaturation, % 9 5 4 2 <0.001
Time with oxygen saturation of less
than 90%, min
64 94 3 11 <0.001
Time with oxygen saturation of less
than 80%, min
17 43 1 1 <0.001
Time of apnea-hypopnea, min 145 86 3 3 <0.001,
by design
Apnea-hypopnea index 50 24 2 1 <0.001,
by design
Arousal index/h 33 20 18 8 <0.001
ns: not significant.
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may serve as a surrogate endpoint for estimation of success
in patients at high risk for adverse cardiovascular
events.11,14 The sustained improvement of large and small
arterial elasticity observed in our study suggests that
improved endothelial function may be the predominant
mechanism of the changes in LAEI and SAEI.19 Although the
exact mechanisms by which arterial elasticity is improved
by CPAP therapy remain to be determined, stimulation of
endothelial nitric oxide synthase may play a role.24
The results of the present study are of particular
interest because all patients underwent polysomnographic
measures. Kitahara et al.25 showed that brachial-ankle
pulse-wave velocity (PWV) e an index of arterial stiffness e
decreased in patients with moderate-to-severe OSA after
four months of CPAP treatment, without significant changes
in total serum cholesterol levels, heart rate, systolic and
diastolic blood pressures, mean blood pressure, and pulse
pressure. These findings are consistent with our results, but
the authors failed to include a matched OSA group or
a sham CPAP group. In this study, SAEI and LAEI did not
improve significantly in the nine OSAþ subjects whoTable 3 Changes in arterial elasticity and other clinical param
Completing CPAP therapy (nZ 35)
Baseline 6 months
Total cholesterol, mmol/L 5.1 0.9 5.1 0.7
HDL cholesterol, mmol/L 1.1 0.2 1.1 0.3
Triglycerides, mmol/L 1.8 0.7 1.7 0.6
BMI, kg/m2 33 6 33 6
SBP, mmHg 141 18 141 18
DBP, mmHg 82 14 82 10
MBP, mmHg 106 22 102 13
HR, beats/min 76 12 71 11
LAEI, mL/mmHg 10 13 4 17 4
SAEI, mL/mmHg 100 6 4 7 3
BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic bloo
artery elasticity index, SAEI: small artery elasticity index, ns: not sigwithdrew from CPAP therapy. Nagahama and colleagues26
reported a significant increase in brachial-ankle PWV in
patients with OSA compared with controls, though poly-
somnography was not performed. Philips et al.27 assessed
arterial stiffness using the aortic augmentation index
before and after two months of CPAP therapy, as well as in
patients withdrawing from CPAP therapy. The authors
found a significant reduction in the aortic augmentation
index in the CPAP group, but not in the withdrawal group.
Recently, Drager and colleagues28 demonstrated that four
months of effective treatment with CPAP significantly
improved carotid intima-media thickness, PWV, levels of C-
reactive protein levels, and catecholamines in normoten-
sive middle-aged men with severe OSA without significant
comorbidities. On the other hand, our sample included
older individuals with a higher frequency of vascular risk
factors. Keles et al.20 have recently shown that CPAP
treatment provides improvement in aortic elastic parame-
ters, but the authors failed to report on changes in small
artery elasticity. To our knowledge, our study is the first to
assess both the LAEI and SAEI compliance parameters in
OSAþ patients undergoing CPAP.eters after 6 months in completers and noncompleters.
P Withdrawn from CPAP therapy (nZ 9) P
Baseline 6 months
ns 5.8 1.1 6.1 1.0 ns
ns 1.3 0.4 1.2 0.3 ns
ns 2.0 0.7 1.8 0.8 ns
ns 30 3 30 3 ns
ns 137 12 137 9 ns
ns 82 9 83 9 ns
ns 100 11 105 11 ns
0.01 74 10 78 8 ns
0.001 13 4 12 2 ns
0.009 5 2 5 1 ns
d pressure, MBP: mean blood pressure; HR: heart rate, LAEI: large
nificant.
Figure 1 Changes in LAEI observed in OSAþ subjects treated by CPAP for 6 months (nZ 35) and in subjects who withdrew from
treatment (nZ 9). LAEI: large artery elasticity index, CPAP: continuous positive airway pressure.
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foremost, we were unable to measure the changes in LAEI
and SAEI at 6 months in subjects without OSA, mainly due to
financial and logistic constraints. For similar reasons, we
did not measure LAEI and SAEI in the 22 OSAþ subjects who
did not receive CPAP treatment. Another limitation is that
applanation tonometry is a noninvasive measure of large
and small arterial elasticity, and an invasive measure would
be more precise. We recognize that the most widespread
noninvasive technique to assess endothelial function is
flow-mediated dilation (FMD). However, FMD is time-Figure 2 Changes in SAEI observed in OSAþ subjects treated by C
treatment (nZ 9). SAEI: small artery elasticity index, CPAP: continconsuming, the equipment is very expensive, and it
requires an experienced examiner.13 Third, the generaliz-
ability of our results may be limited by the small sample
size. It is noteworthy, however, that two thirds of subjects
referred to our sleep laboratory for the evaluation of OSA
revealed a pathologic result. This result highlights the need
for increased awareness of this frequently neglected
pathological condition. Finally, this study was designed as
an exploratory pilot project. Although the improvement in
large and small arterial elasticity was clear, our data need
to be confirmed in randomized, placebo-controlled studies.PAP for 6 months (nZ 35) and in subjects who withdrew from
uous positive airway pressure.
1576 S. Eryılmaz et al.The primary outcome measure in this study was arterial
elasticity and thus the study was not powered to detect
changes in the clinical outcome as a result of CPAP treat-
ment in OSAþ subjects. Greater numbers and longer
treatment duration are required to evaluate this possibility
fully. However, our findings provide a strong rationale for
such a study.
In conclusion, we have shown an increase in arterial
elasticity in OSAþ subjects after six months of CPAP
treatment. These observations are likely to represent
another beneficial vascular effect of CPAP therapy in this
patient group.
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